title: Large Porous Hollow Particles: Lightweight Champions of Pulmonary Drug Delivery.
abstract: The deep lungs provide an efficient pathway for drugs to transport into the systemic circulation, as the extremely large surface area and thin epithelial membrane enable rapid drug transport to the blood stream. To penetrate into the deep lungs, aerosol particles with aerodynamic diameters of 1-3 µm are optimal. Large porous hollow particles (LPHPs) can achieve this aerodynamic size range through enhanced porosity within the particles (typically < 0.4 g/cm(3)), which aerodynamically balances the large particle size (> 5 µm, up to 30 µm). The physical properties of these particles provide some key advantages compared to their small, nonporous counterparts through enhanced dispersibility, efficient deep lung deposition, and avoidance of phagocytic clearance. This review highlights the potential of LPHPs in pulmonary delivery of systemic drugs, with a focus on their critical attributes and key formulation aspects. In addition, three examples of LPHPs under development are presented to emphasize the potential of this technology to treat systemic diseases.
authors.forename: Sachin
authors.initials: S
authors.lastname: Gharse
authors.affiliation: University of Iowa, 4133 Seamans Center for the Engineering Arts and Sciences, Iowa City, IA 52245. jennifer-fiegel@uiowa.edu.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Fiegel
mesh_terms: D000818:Animals; D016503:Drug Delivery Systems; D006801:Humans; D008168:Lung / Q000378:metabolism*; D010316:Particle Size; D016062:Porosity; D013499:Surface Properties
references.citation: J Aerosol Med. 2005 Winter;18(4):452-9
references.pmid: 16379620
references.citation: Int J Pharm. 2002 Apr 2;236(1-2):65-79
references.pmid: 11891071
references.citation: Mol Pharm. 2015 Aug 3;12(8):2642-50
references.pmid: 25942002
references.citation: J Control Release. 2004 Apr 28;96(2):233-44
references.pmid: 15081215
references.citation: Thromb J. 2015 Apr 16;13:15
references.pmid: 25883536
references.citation: Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9867-72
references.pmid: 15226520
references.citation: Langmuir. 2006 Jul 4;22(14):6024-30
references.pmid: 16800655
references.citation: J Control Release. 2008 Jun 24;128(3):224-32
references.pmid: 18471921
references.citation: J Control Release. 1998 Feb 12;51(2-3):143-52
references.pmid: 9685911
references.citation: Am J Physiol Lung Cell Mol Physiol. 2012 Jan 15;302(2):L193-205
references.pmid: 22003091
references.citation: J Control Release. 2002 Feb 19;79(1-3):29-40
references.pmid: 11853916
references.citation: Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12001-5
references.pmid: 12200546
references.citation: J Control Release. 2009 Apr 2;135(1):25-34
references.pmid: 19154761
references.citation: Respir Res. 2011 May 27;12:70
references.pmid: 21619599
references.citation: Respir Care. 2005 Sep;50(9):1139-50
references.pmid: 16122398
references.citation: J Control Release. 2004 May 18;96(3):411-23
references.pmid: 15120898
references.citation: Int J Pharm. 2009 Jan 5;365(1-2):162-9
references.pmid: 18782609
references.citation: J Control Release. 2012 Sep 10;162(2):310-20
references.pmid: 22800582
references.citation: Pharm Res. 1999 Apr;16(4):555-61
references.pmid: 10227712
references.citation: Science. 1997 Jun 20;276(5320):1868-71
references.pmid: 9188534
references.citation: Prim Care Respir J. 2007 Apr;16(2):71-81
references.pmid: 17356785
references.citation: J Control Release. 2007 Mar 12;118(1):78-86
references.pmid: 17241685
references.citation: Adv Drug Deliv Rev. 2006 Oct 31;58(9-10):996-1008
references.pmid: 16996638
references.citation: Int J Pharm. 2013 Oct 1;454(2):668-77
references.pmid: 23603099
references.citation: J Control Release. 2001 Feb 23;70(3):329-39
references.pmid: 11182203
references.citation: Chest. 2003 Jul;124(1):360-6
references.pmid: 12853545
references.citation: Part Fibre Toxicol. 2012 Aug 28;9:34
references.pmid: 22929371
references.citation: Mem Inst Oswaldo Cruz. 2006 Nov;101(7):697-714
references.pmid: 17160276
references.citation: South Med J. 2000 May;93(5):507-10
references.pmid: 10832953
references.citation: Br J Clin Pharmacol. 2003 Dec;56(6):588-99
references.pmid: 14616418
references.citation: Am Fam Physician. 2005 Nov 1;72(9):1761-8
references.pmid: 16300038
references.citation: Horm Metab Res. 2003 Sep;35(9):557-61
references.pmid: 14517774
references.citation: Pharm Res. 2000 Feb;17(2):168-74
references.pmid: 10751031
references.citation: Int J Nanomedicine. 2014 Jul 25;9:3527-38
references.pmid: 25114523
references.citation: Prim Care Respir J. 2006 Dec;15(6):326-31
references.pmid: 17092772
references.citation: J Clin Endocrinol Metab. 2009 Jun;94(6):2052-9
references.pmid: 19336514
references.citation: Pharm Res. 2008 Apr;25(4):805-11
references.pmid: 17657592
references.citation: Biotechnol Ther. 1989-1990;1(3):213-28
references.pmid: 2562650
references.citation: Biomaterials. 2009 Apr;30(10):1947-53
references.pmid: 19135245
references.citation: Pharm Res. 2000 Mar;17(3):275-83
references.pmid: 10801215
references.citation: Pharm Res. 2002 May;19(5):689-95
references.pmid: 12069174
references.citation: Pharm Res. 2008 May;25(5):999-1022
references.pmid: 18040761
references.citation: J Pharm Sci. 2008 Jan;97(1):287-302
references.pmid: 17823950
references.citation: Nat Rev Drug Discov. 2007 Jan;6(1):67-74
references.pmid: 17195033
references.citation: Antimicrob Agents Chemother. 2007 Aug;51(8):2830-6
references.pmid: 17517845
references.citation: AAPS J. 2010 Dec;12(4):699-707
references.pmid: 20878294
references.citation: Pharm Res. 2008 Aug;25(8):1815-21
references.pmid: 18373181
references.citation: JAMA. 2005 Feb 9;293(6):681-9
references.pmid: 15701909
references.citation: J Cell Sci. 1992 Apr;101 ( Pt 4):907-13
references.pmid: 1527185
references.citation: Pharm Res. 2007 Mar;24(3):411-37
references.pmid: 17245651
references.citation: J Control Release. 2006 May 15;112(2):167-74
references.pmid: 16542746
references.citation: J Appl Physiol (1985). 1998 Aug;85(2):379-85
references.pmid: 9688708
references.citation: J Control Release. 2007 Aug 16;121(1-2):100-9
references.pmid: 17604870
references.citation: Drugs. 2000 Feb;59(2):171-9
references.pmid: 10730543
references.citation: Int J Antimicrob Agents. 1999 Oct;13(2):93-7
references.pmid: 10595567
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4930-4
references.pmid: 16549762
references.citation: Tuberculosis (Edinb). 2003;83(6):379-85
references.pmid: 14623169
references.citation: Int J Pharm. 2002 Oct 1;245(1-2):179-89
references.pmid: 12270254
references.citation: Drugs. 2014 Feb;74(2):243-62
references.pmid: 24430916
references.citation: Eur J Pharm Sci. 2010 Sep 11;41(1):60-70
references.pmid: 20510360
references.citation: Pharm Res. 1999 Nov;16(11):1735-42
references.pmid: 10571280
references.citation: J Control Release. 2010 Aug 17;146(1):61-7
references.pmid: 20553775